ALGT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ALGT is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has a bullish technical setup, but analyst targets have been cut recently, insiders are heavy sellers, and there is no fresh news or financial-quarter catalyst to support an aggressive long-term entry. With no AI Stock Picker or SwingMax signal, this looks like a hold rather than a buy at the current price.
Price is 88.95, below the prior close of 90.73 and near the R1 level at 89.847, showing short-term hesitation after a recent advance. The MACD histogram is positive and expanding, which supports upward momentum. The moving averages are bullish with SMA_5 > SMA_20 > SMA_200, confirming an established uptrend. RSI_6 at 73.531 is elevated, suggesting the stock is already extended rather than offering a clean beginner-friendly entry. Overall, the trend is bullish, but the current spot is not especially attractive after the recent run.
["Bullish price structure with SMA_5 > SMA_20 > SMA_200", "MACD histogram is positive and expanding", "Options flow favors calls over puts", "Hedge funds are buying, with buying up 507.50% over the last quarter", "Stock pattern analysis suggests a positive 1-month drift of 4.12%"]
["No news in the recent week, so no fresh event-driven catalyst", "Insiders are selling heavily, with selling up 150894.53% over the last month", "Analyst price targets have been cut recently by Citi and UBS", "UBS and Citi both keep Neutral ratings, limiting conviction", "RSI is elevated, so the stock is not a fresh low-risk entry"]
No latest-quarter financial snapshot was available because the provided financial data returned an error. As a result, there is no usable recent-quarter revenue or earnings trend to confirm fundamental momentum. The latest-quarter season cannot be determined from the provided data.
Analyst sentiment is mixed to cautious. UBS raised its target to $93 from $90 but kept a Neutral rating on 2026-03-23. Citi cut its target to $98 from $114 and also kept Neutral on 2026-03-20. UBS previously lowered its target to $90 from $102 on 2026-03-16, while Evercore ISI was more constructive on 2026-03-12 with an Outperform rating and a $120 target, down from $125. Overall, Wall Street is split, but the recent trend is downward target revisions with neutral positioning, which is a mild negative.
